2022 SHM Periop Update References

1.https://www.sciencedirect.com/science/article/pii/S2405603021000868

2.Benesch C, Glance LG, Derdeyn CP, Fleisher LA, Holloway RG, Messé SR, Mijalski C, Nelson MT, Power M, Welch BG; American Heart Association Stroke Council; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epidemiology and Prevention. Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association. Circulation. 2021 May 11;143(19):e923-e946. doi: 10.1161/CIR.0000000000000968. Epub 2021 Apr 8. PMID: 33827230.

3.Wilson TA, de Koning L, Quinn RR, Zarnke KB, McArthur E, Iskander C, Roshanov PS, Garg AX, Hemmelgarn BR, Pannu N, James MT. Derivation and External Validation of a Risk Index for Predicting Acute Kidney Injury Requiring Kidney Replacement Therapy After Noncardiac Surgery. JAMA Netw Open. 2021 Aug 2;4(8):e2121901. doi: 10.1001/jamanetworkopen.2021.21901. PMID: 34424303; PMCID: PMC8383136.

4.Kovacs MJ, Wells PS, Anderson DR, Lazo-Langner A, Kearon C, Bates SM, Blostein M, Kahn SR, Schulman S, Sabri E, Solymoss S, Ramsay T, Yeo E, Rodger MA; PERIOP2 Investigators. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205. PMID: 34108229; PMCID: PMC8188228.

5.Weersink CSA, van Waes JAR, Grobben RB, Nathoe HM, van Klei WA. Patient Selection for Routine Troponin Monitoring After Noncardiac Surgery. J Am Heart Assoc. 2021 Jul 20;10(14):e019912. doi: 10.1161/JAHA.120.019912. Epub 2021 Jul 3. PMID: 34219462; PMCID: PMC8483467.

6.PRISM trial group. Postoperative continuous positive airway pressure to prevent pneumonia, re-intubation, and death after major abdominal surgery (PRISM): a multicentre, open-label, randomised, phase 3 trial. Lancet Respir Med. 2021 Nov;9(11):1221-1230. doi: 10.1016/S2213-2600(21)00089-8. Epub 2021 Jun 18. Erratum in: Lancet Respir Med. 2021 Sep;9(9):e95. PMID: 34153272.

7.van Norden J, Spies CD, Borchers F, Mertens M, Kurth J, Heidgen J, Pohrt A, Mueller A. The effect of peri-operative dexmedetomidine on the incidence of postoperative delirium in cardiac and non-cardiac surgical patients: a randomised, double-blind placebo-controlled trial. Anaesthesia. 2021 Oct;76(10):1342-1351. doi: 10.1111/anae.15469. Epub 2021 May 7. PMID: 33960404.

8.Qin C, Jiang Y, Lin C, Li A, Liu J. Perioperative dexmedetomidine administration to prevent delirium in adults after non-cardiac surgery: A systematic review and meta-analysis. J Clin Anesth. 2021 Oct;73:110308. doi: 10.1016/j.jclinane.2021.110308. Epub 2021 Apr 28. PMID: 33930679.

9.Mahmud N, Fricker Z, Panchal S, Lewis JD, Goldberg DS, Kaplan DE. External Validation of the VOCAL-Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems. Liver Transpl. 2021 Jul;27(7):961-970. doi: 10.1002/lt.26060. PMID: 33788365; PMCID: PMC8283779.

10.Mahmud N, Fricker Z, Lewis JD, Taddei TH, Goldberg DS, Kaplan DE. Risk Prediction Models for Postoperative Decompensation and Infection in Patients With Cirrhosis: A Veterans Affairs Cohort Study. Clin Gastroenterol Hepatol. 2021 Jul 8:S1542-3565(21)00721-7. doi: 10.1016/j.cgh.2021.06.050. Epub ahead of print. PMID: 34246794; PMCID: PMC8741885.